AC Immune Therapy chosen for groundbreaking Alzheimer's Disease Trial in Colombia and USA

May 16, 2012
  • World's first Alzheimer's disease prevention trial before onset of symptoms in highest-risk individuals
  • Trial funded by National Institutes of Health, Banner Alzheimer's Institute and Genentech
  • Antibody discovered by AC Immune and exclusively licensed to Genentech